E

Emilie Robin

ArcelorMittal (Belgium)

Publishes on Mosquito-borne diseases and control, Viral Infections and Vectors, SARS-CoV-2 and COVID-19 Research. 8 papers and 3.3k citations.

8Publications
3.3kTotal Citations

Is this you? Claim your profile.

Add your photo, update your bio, and get notified when your ranking changes.

Top publicationsby citations

Potential Sexual Transmission of Zika Virus
Didier Musso, Claudine Roche, Emilie Robin et al.|Emerging infectious diseases|2015
Cited by 1.2kOpen Access

In December 2013, during a Zika virus (ZIKV) outbreak in French Polynesia, a patient in Tahiti sought treatment for hematospermia, and ZIKV was isolated from his semen. ZIKV transmission by sexual intercourse has been previously suspected. This observation supports the possibility that ZIKV could be transmitted sexually.

Zika Virus, French Polynesia, South Pacific, 2013
Van‐Mai Cao‐Lormeau, Claudine Roche, Anita Teissier et al.|Emerging infectious diseases|2014
Cited by 864Open Access

To the Editor: Isolated in 1947 from a rhesus monkey in Zika forest, Uganda, Zika virus (ZIKV) is a mosquito-borne flavivirus (1). For half a century, ZIKV was described only as causing sporadic human infections in Africa and Asia, which was mostly confirmed by serologic methods (2). In 2007, the first ZIKV outbreak reported outside Africa and Asia was retrospectively documented from biological samples of patients on Yap Island, Federated States of Micronesia, North Pacific, who had received an incorrect diagnosis of dengue virus (DENV) (3,4). We report here the early investigations that led to identification of ZIKV as the causative agent of an outbreak that started in October 2013 in French Polynesia.

Potential for Zika virus transmission through blood transfusion demonstrated during an outbreak in French Polynesia, November 2013 to February 2014
Didier Musso, Tu‐Xuan Nhan, Emilie Robin et al.|Eurosurveillance|2014
Cited by 694Open Access

Since October 2013, French Polynesia has experienced the largest documented outbreak of Zika virus (ZIKAV) infection. To prevent transmission of ZIKAV by blood transfusion, specific nucleic acid testing of blood donors was implemented. From November 2013 to February 2014: 42 (3%) of 1,505 blood donors, although asymptomatic at the time of blood donation, were found positive for ZIKAV by PCR. Our results serve to alert blood safety authorities about the risk of post-transfusion Zika fever.